Mechanisms of Paradoxical Activation of AMPK by the Kinase Inhibitors SU6656 and Sorafenib

SU6656, a Src kinase inhibitor, was reported to increase fat oxidation and reduce body weight in mice, with proposed mechanisms involving AMP-activated protein kinase (AMPK) activation via inhibition of phosphorylation of either LKB1 or AMPK by the Src kinase, Fyn. However, we report that AMPK activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, Fiona A., Hawley, Simon A., Auciello, F. Romana, Gowans, Graeme J., Atrih, Abdelmadjid, Lamont, Douglas J., Hardie, D. Grahame
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522529/
https://www.ncbi.nlm.nih.gov/pubmed/28625738
http://dx.doi.org/10.1016/j.chembiol.2017.05.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522529/
https://www.ncbi.nlm.nih.gov/pubmed/28625738
http://dx.doi.org/10.1016/j.chembiol.2017.05.021

Ejemplares similares